The UK’s Department for Business and Trade supports international investment into the UK and UK businesses to grow and export. Whether you’re interested in clinical research for innovative products, working with the UK’s world-leading universities, SMEs and spin outs, leveraging our globally-unique datasets or manufacturing complex products at pace and scale, the UK has a strong offer spanning Northern Ireland, Scotland and Wales and would like to work with you. We are joined by 16 inspired, innovative and international UK co-exhibitors eager to connect with you. | Connect with the UK Invest in the UK: Access free, confidential advice and support on your inward investment journey. Buy from the UK: The UK’s thriving life sciences sector has a lot to offer the world, from innovative products to expert services. Export from the UK: We Provide insights, training, events, finance and expert support so exporters can realise the full benefits of internationalising. Innovate with the UK: Connect into our networks to partner with UK academia, research institutes, centres of excellent and spinouts. Talk to us today and continue connecting with the UK in your home country via our teams based in over 100 international markets. | This UK government department specialises in helping UK businesses and bringing investment into the UK.
DELFI Diagnostics
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI platform is built to address the highest-burden health challenges. We prioritize solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI’s platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. For more information, visit www.delfidiagnostics.com. | DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer. DELFI tests are built to solve the highest-burden population health issues, including in historically underserved demographics, and have the potential to save lives on a global scale. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and requires a simple blood draw that can be incorporated with routine blood work. The test is based on fragmentomics, the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals’ cfDNA fragments against populations with and without cancer. FirstLook Lung uses these millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early-stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. To learn more about the FirstLook Lung test, visit www.delfidiagnostics.com or www.firstlooktest.com.
Del Medical
Del Medical is a leading U.S. manufacturer and global distributor of high-quality, cost-effective radiographic solutions for orthopedic practices, hospitals, and other medical imaging centers. Our open-architecture systems and complete portfolio of digital detectors deliver flexible, integrated solutions, backed by a worldwide network of authorized, factory-trained dealers for expert support and service. | Del Medical is a leading US manufacturer and global distributor of high quality, durable and affordable radiographic solutions for hospitals, orthopedic and urgent care facilities, urology practices, and other medical imaging centers. Solutions include high-capacity radiographic rooms and components, R/F Systems, PACS and a complete portfolio of Wireless & Fixed Cesium DR Detector solutions. Del Medical’s open architecture gives customers the flexibility to combine its industry-leading radiographic components with state-of-the-art digital solutions as retrofits to existing rooms or as integrated solutions at the time of a new room purchase. The Del Medical portfolio of radiographic solutions is sold and serviced through a network of authorized and factory trained local imaging dealers. | Del Medical is a leading U.S. manufacturer and global distributor of high-quality, dependable, and cost-effective radiographic solutions for hospitals, urgent care facilities, orthopedic practices, chiropractic offices, veterinary clinics, urology departments, and other medical imaging centers. Our portfolio spans high-capacity radiographic rooms and components, R/F systems, PACS, and a full range of wireless and fixed Cesium DR detectors. With an open-architecture design, Del Medical gives customers the flexibility to pair our industry-leading radiographic components with state-of-the-art digital solutions, whether retrofitting an existing room or installing a fully integrated system. Backed by a global network of authorized, factory-trained imaging dealers, we deliver expert support and service every step of the way.
DeepTek Inc
Incorporated in the U.S. in 2017, DeepTek is amongst very few medical imaging AI start-ups, which has successfully established commercial adoption of AI technology in clinical practice–creating clear and quantifiable value for patients, hospitals, and radiologists. DeepTek’s vision is to provide cutting-edge solutions powered by deep learning algorithms that will bridge the wide gap in the imaging sector. DeepTek products have bagged multiple regulatory clearances including the coveted US FDA and CE Clearance. DeepTek is currently serving over 1000 hospitals across India, US, Singapore, Thailand, the Philippines, Nigeria, Kenya, and several other countries. In Singapore – DeepTek’s solution has been adopted as a National Radiology AI platform. DeepTek touches the lives of more than a million individuals every year. DeepTek.ai has a team of 200+ members with a unique mix of technology experts and radiologists and is trusted by marquee equity partners like TATA Capital Healthcare Fund II and NTT DATA.
Decode Cure Limited
Decode Cure Limited specializes in rapid microbial identification using proprietary genomics and big data analytics for clinical, environmental, and research applications. Decode Cure’s mission is to reduce mortality rates and medical expenses associated with complex diseases by enabling faster and more accurate diagnoses. Our system can rapidly identify pathogens that cause respiratory tract illness, other complex human diseases, like cancer, Alzheimer’s disease and environmental issues. Decode Cure’s products have earned recognition and validation through respected external quality programs like College of American Pathologists and Quality Control for Molecular Diagnostics. Our solutions are instrumental in analyzing diverse samples for government, non-profit, and for-profit organizations, addressing critical health and environmental challenges.
Dawei Medical (Jiangsu) Co., Ltd.
DAWEI: Medical equipment manufacturer, specializing in ultrasound, ECG, monitors, X-rays since 2006
Dakewe (Biosci & Exreprotein)
Dakewe group was founded in 1999 and is headquartered in Shenzhen, China. Our business involves in self-developed histology equipment and scientific research reagents. Dakewe group has more than 14 branches based both in China and overseas, including Beijing, Shanghai, Hong Kong, USA, Europe and India, and more. Meanwhile, Dakewe is consistently complementing the service and distribution network to provide quality products and service to customers all around the world. Dakewe products have been sold to more than 60 countries/regions and served more than 10000 users.
Daicel Life Sciences
Daicel Life Sciences provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver biologicals, including Nucleic acids, without the use of needles, LNPs or other carriers. Delivery can be SC, ID, or IM. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method. | Daicel Life Sciences provides products and services to a wide array of the Pharmaceutical market. In the area of drug delivery, our Actranza lab. device is designed to inject biological drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, this unique needle-free injector has been proven to deliver mRNA and DNA into the cell and achieve production of the desired protein or antibody. | Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.
D&D FILTRATION
D&D Filtration is a premier filtration consultant and supplier specializing in high-end filtration products and services. As a stocking distributor, we provide rapid access to industry-leading filtration solutions while leveraging our deep technical knowledge and expertise to support our clients in optimizing their processes. What sets D&D apart is our hands-on, consultative approach—we don’t just sell products; we embed ourselves into our clients’ operations, actively listening to their pain points and tailoring solutions that enhance efficiency, scalability, and cost-effectiveness. We proudly serve a diverse range of industries, including pharmaceutical & biotech, industrial manufacturing, cosmetics, and food & beverage, ensuring that every sector benefits from our customized, high-performance filtration solutions. Whether improving monoclonal antibody production, refining depth filtration processes, or optimizing industrial fluid management, D&D Filtration is the trusted partner for businesses seeking expert guidance and top-tier filtration technology | D&D Filtration serves all New England states, New York, New Jersey, Delaware, Maryland, Virginia, and Eastern Pennsylvania. D&D Filtration was started in 1988 and serves a diverse filter market that includes Biopharmaceutical, Semiconductor, Coating, Chemical, Industrial, Food and Beverage, Utility, and other industries. D&D Filtration not only provides product and service, but also consults to assist in resolving many of the most difficult problems in filtration.